What is the current price of a box of trametinib targeted drug?

Trametinib is a targeted drug used to treat BRAF V600 mutation-positive melanoma and other specific solid tumors. Its trade name in China is "Megenin" and it was originally developed by Novartis. The drug has been approved for marketing in China and has been included in the national medical insurance catalog, effectively alleviating patients' medication burden. In the domestic market, trametinib is available in two specifications: 0.5mg 30 tablets and 2mg 30 tablets, which can be flexibly selected according to the doctor's advice.

Judging from the current market price, the domestic price of trametinib in 0.5mg30 tablets ranges from 3000 to The price is about 4,000yuan, while the price of 2mg30 tablets is higher, generally ranging from 9,000 to more than 10,000 yuan. Since this drug has been included in medical insurance, the actual amount paid by the patient will vary depending on the regional medical insurance reimbursement ratio. It is recommended to go to the local hospital pharmacy or medical insurance center to obtain specific price and reimbursement information.

In foreign markets, there are also multiple versions of trametinib circulating, among which the Turkish original version is more common. According to public data, the price of trametinib for 2mg*30 tablets in the Turkish market is about 7,000 to 8,000 yuan, which is slightly lower than the domestic non-medical insurance price. Some patients obtain this version through overseas purchasing channels in order to seek more cost-effective treatment options, but they need to pay attention to choosing formal channels to ensure reliable sources of drugs.

In addition, the Lao Ministry of Health has officially approved the listing of generic trametinib, becoming a lower-priced alternative in the current overseas market. The Lao version of generic drugs has the same specifications as the original drugs and the same ingredients. It is mainly used to meet the treatment needs of patients with limited economic conditions. Currently, the latest selling price of this version is 1,000 multiple yuan, which has become an important way for some patients to ease their financial burden. However, it needs to be reminded that generic drugs should be used under the guidance of a doctor to ensure therapeutic effect and drug safety.

Reference materials:https://go.drugbank.com/drugs/DB08911